Related Experiment Videos
The structure, function, and turnover of cardiac myosin in normal and myopathic Syrian hamsters
Insights
Cardiac myosin function declines in late-stage cardiomyopathy in Syrian hamsters. This inherited heart disease alters protein metabolism, increasing myosin degradation and reducing ATPase activity without changing myosin structure.
Area of Science:
- Cardiology
- Biochemistry
- Molecular Biology
Background:
- Cardiomyopathy is a progressive heart muscle disease.
- Syrian hamsters (BIO 14.6 strain) exhibit an inherited form of cardiomyopathy.
- Cardiac myosin is crucial for heart muscle contraction.
Purpose of the Study:
- To investigate changes in cardiac myosin during the progression of inherited cardiomyopathy.
- To determine if alterations in myosin structure or activity are associated with disease stages.
- To examine protein metabolism in diseased cardiac tissue.
Main Methods:
- Analysis of ventricular myosin from Syrian hamsters at four pathologic stages of cardiomyopathy.
- Measurement of Ca2+- and K+-ethylenediaminetetraacetic acid (EDTA)-activated ATPase activities.
- One- and 2-dimensional gel electrophoresis to assess myosin subunit structure.
- Evaluation of myosin synthesis and degradation rates.
Main Results:
- Ventricular myosin ATPase activities were significantly reduced in the final stage of cardiomyopathy.
- Myosin subunit structure (light chain number, molecular weight, composition) remained unchanged throughout disease stages.
- Altered protein metabolism, including increased degradation rates, was observed in diseased cardiac tissue.
- A net loss of cardiac myosin resulted from increased degradation.
Conclusions:
- Inherited cardiomyopathy in Syrian hamsters leads to reduced cardiac myosin function.
- The functional decline is attributed to altered protein metabolism and increased myosin degradation, not structural changes.
- These findings highlight the role of protein turnover in the pathogenesis of this cardiac disease.
Abstract:
Cardiac myosin was examined during the four pathologic stages of cardiomyopathy in strain BIO 14.6 of Syrian hamsters. It was determined that the Ca2+- and K+-ethylenediaminetetraacetic acid (EDTA)-activated ATPase activities of ventricular myosin were significantly reduced during the final stage of the inherited disease. One- and 2-dimensional gel electrophoresis of myosin samples at all stages failed to yield any evidence for a change in the subunit structure of myosin based on light chain number, molecular weight, and per cent composition. The final stage of the disease was characterized by altered protein metabolism. The rates of synthesis and degradation were both altered in the diseased tissue, and a net loss of myosin resulting from a substantial increase in the rate of degradation.